Clinical Diagnosis of Lung Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pulmonology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 168
Special Issue Editors
Interests: VATS lung resection (lobectomy, segmentectomy); pancoast tumor and airway reconstruction; robotic surgery (mediastinal and lung tumor); pleurectomy decortication for mesothelioma; tracheal surgery; thymoma early and advanced stage surgery; chest wall resection and reconstruction; robotic surgery
2. Department of Thoracic Surgery, 424 General Military Hospital, Thessaloniki, Greece
Interests: minimally invasive surgery; robotic surgery; translational cardiovascular medicine; military medicine; health policy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Accurate and timely diagnosis is critical for the effective management of lung cancer, the leading cause of cancer-related mortality worldwide. This Special Issue of the Journal of Clinical Medicine will provide an overview of the latest developments in the clinical diagnosis of lung cancer. We welcome original research and comprehensive reviews that showcase recent advances across the continuum of lung cancer diagnosis—from screening and early detection to molecular testing and biomarker discovery. Key topics to be covered include the implementation of lung cancer screening programs, the comparative effectiveness of different imaging modalities, innovations in endoscopic techniques and minimally invasive staging, the role of liquid biopsies, and the validation of emerging molecular biomarkers.
By highlighting cutting-edge findings across diverse disciplines, this issue aims to promote multidisciplinary collaboration and the adoption of best practices. The goal is to achieve earlier diagnosis, more accurate subtyping, and improved staging. The insights presented may guide clinicians in maximizing diagnostic precision, aiding them in selecting optimal treatment approaches and personalized monitoring strategies. Overall, by facilitating state-of-the-art lung cancer diagnosis, this collection of articles can ultimately help to improve patient outcomes for this deadly disease.
Dr. Andrea Bille
Dr. Savvas Lampridis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- bronchoscopy
- diagnosis
- imaging
- liquid biopsy
- lung cancer
- mediastinoscopy
- minimally invasive surgery
- pathology
- screening
- staging
